Stuart Andrew MP: written questions
247 published records · newest first.
Written questions
Surgery: TrainingDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3233More
Question: To ask the Secretary of State for Health and Social Care, what plans his Department has to support advanced specialist surgical skills development in areas previously supported by Training Interface Group fellowships, including cleft, ENT, plastic, hand a
Answer: NHS England made the decision in 2025 to discontinue central funding of the salary support component of the Training Interface Group (TIG) programme, and to target financial resources more effectively to address regional workforce priorities.Regions or pr...
Answered 1 Jun 2026
Original Parliament recordSurgery: TrainingDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3232More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the number of Training Interface Group fellowship posts affected by the withdrawal of central funding and national support, broken down by surgical
Answer: NHS England made the decision in 2025 to discontinue central funding of the salary support component of the Training Interface Group (TIG) programme, and to target financial resources more effectively to address regional workforce priorities.Regions or pr...
Answered 1 Jun 2026
Original Parliament recordMedical Treatments: InnovationDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3231More
Question: To ask the Secretary of State for Health and Social Care, whether NHS England will commission a national assessment of regional variation in access to left atrial appendage occlusion or closure services.
Answer: NHS England has not undertaken national assessment of the impact of centralisation of left atrial appendage occlusion (LAAO) services on travel or waiting times and there are also no plans to undertake a review of regional variation. These services are de...
Answered 1 Jun 2026
Original Parliament recordMedical Treatments: InnovationDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3230More
Question: To ask the Secretary of State for Health and Social Care, what assessment NHS England has made of the impact of centralisation of left atrial appendage occlusion or closure services on patient travel times and waiting times.
Answer: NHS England has not undertaken national assessment of the impact of centralisation of left atrial appendage occlusion (LAAO) services on travel or waiting times and there are also no plans to undertake a review of regional variation. These services are de...
Answered 1 Jun 2026
Original Parliament recordMedical Treatments: InnovationDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3229More
Question: To ask the Secretary of State for Health and Social Care, how many provider centres approved to deliver left atrial appendage occlusion or closure services are currently inactive or not routinely delivering procedures; and what steps NHS England is taking
Answer: NHS England has not undertaken national assessment of the impact of centralisation of left atrial appendage occlusion (LAAO) services on travel or waiting times and there are also no plans to undertake a review of regional variation. These services are de...
Answered 1 Jun 2026
Original Parliament recordMedical Treatments: InnovationDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3228More
Question: To ask the Secretary of State for Health and Social Care, whether NHS England routinely monitors geographical variation in the delivery of specialised services including left atrial appendage occlusion or closure; and what action it takes where provision
Answer: NHS England has not undertaken national assessment of the impact of centralisation of left atrial appendage occlusion (LAAO) services on travel or waiting times and there are also no plans to undertake a review of regional variation. These services are de...
Answered 1 Jun 2026
Original Parliament recordShingles: VaccinationDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3227More
Question: To ask the Secretary of State for Health and Social Care, what operational, clinical or supply-side factors informed the decision to phase the expansion of the shingles vaccination programme to adults aged 60 and over between 2028 and 2033.
Answer: The shingles vaccine was previously available as part of the national immunisation programme to those aged 70 years old and over. In 2019, the Joint Committee on Vaccination and Immunisation (JCVI) recommended that the shingles vaccination programme shoul...
Answered 30 Jun 2026
Original Parliament recordShingles: VaccinationDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3226More
Question: To ask the Secretary of State for Health and Social Care, what factors his Department is considering before responding to the Joint Committee on Vaccination and Immunisation’s November 2024 advice that the shingles vaccination programme should be expanded
Answer: The Government is considering the Joint Committee on Vaccination and Immunisation’s advice on shingles vaccinations, examining factors including clinical benefits, affordability and cost effectiveness.No decision has yet been taken on any expansion of the...
Answered 30 Jun 2026
Original Parliament recordShingles: VaccinationDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3225More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that adults who are already older than the eligible age when the shingles vaccination programme is expanded are not disadvantaged by the timing of the rollout.
Answer: The Government is considering the Joint Committee on Vaccination and Immunisation’s advice on shingles vaccinations, examining factors including clinical benefits, affordability and cost effectiveness.No decision has yet been taken on any expansion of the...
Answered 30 Jun 2026
Original Parliament recordShingles: VaccinationDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3224More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the clinical, operational, procurement and supply-side barriers to expanding the shingles vaccination programme to adults aged 80 and over.
Answer: The Government is considering the Joint Committee on Vaccination and Immunisation’s advice on shingles vaccinations, examining factors including clinical benefits, affordability and cost effectiveness.No decision has yet been taken on any expansion of the...
Answered 30 Jun 2026
Original Parliament recordShingles: Older PeopleDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3223More
Question: To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the cost to the NHS of shingles-related GP appointments, A&E attendances and hospital admissions among adults aged 80 and over between the Joint Committee o
Answer: The Government is considering the Joint Committee on Vaccination and Immunisation’s advice on shingles vaccinations, examining factors including clinical benefits, affordability and cost effectiveness.No decision has yet been taken on any expansion of the...
Answered 30 Jun 2026
Original Parliament recordShingles: Older PeopleDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3222More
Question: To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of adults aged 80 and over who may develop shingles between the Joint Committee on Vaccination and Immunisation’s November 2024 advice on expandi
Answer: The Government is considering the Joint Committee on Vaccination and Immunisation’s advice on shingles vaccinations, examining factors including clinical benefits, affordability and cost effectiveness.No decision has yet been taken on any expansion of the...
Answered 30 Jun 2026
Original Parliament recordCannabis: Medical TreatmentsDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3221More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has asked the Advisory Council on the Misuse of Drugs to consider patient safety issues in its review of cannabis-based products for medicinal use, including prescribing to p
Answer: The Department of Health and Social Care has worked closely with the Home Office and the Medicines and Healthcare products Regulatory Agency (MHRA) in the development and implementation of the law change in 2018 to permit the prescribing of unlicensed can...
Answered 1 Jun 2026
Original Parliament recordCannabis: Medical TreatmentsDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3220More
Question: To ask the Secretary of State for Health and Social Care, whether the Advisory Council on the Misuse of Drugs’ review of cannabis-based products for medicinal use will specifically consider prescribing to patients with serious mental illness, advertising
Answer: The Department of Health and Social Care has worked closely with the Home Office and the Medicines and Healthcare products Regulatory Agency (MHRA) in the development and implementation of the law change in 2018 to permit the prescribing of unlicensed can...
Answered 1 Jun 2026
Original Parliament recordCannabisHome OfficeTabled 20 May 2026AnsweredUIN 3219More
Question: To ask the Secretary of State for the Home Department, on what dates the Cannabis Interchange Group has met since 1 January 2020; who attended each meeting; and whether she plans to publish the agendas, minutes and papers of those meetings.
Answer: The Home Office is not aware of a group called “the Cannabis Interchange Group”. Officials from the Home Office and the Department of Health and Social Care liaise frequently on issues connected to the use of controlled drugs in healthcare, including Cann...
Answered 1 Jun 2026
Original Parliament recordCannabis: Medical TreatmentsDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3218More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of current arrangements for monitoring prescribing volumes of cannabis-based products for medicinal use by provider and prescriber.
Answer: The Department of Health and Social Care has worked closely with the Home Office and the Medicines and Healthcare products Regulatory Agency (MHRA) in the development and implementation of the law change in 2018 to permit the prescribing of unlicensed can...
Answered 1 Jun 2026
Original Parliament recordCannabis: Medical TreatmentsDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3217More
Question: To ask the Secretary of State for Health and Social Care, what discussions his Department has had with the MHRA on the regulation of private clinics advertising consultations for cannabis-based products for medicinal use.
Answer: The Department of Health and Social Care has worked closely with the Home Office and the Medicines and Healthcare products Regulatory Agency (MHRA) in the development and implementation of the law change in 2018 to permit the prescribing of unlicensed can...
Answered 1 Jun 2026
Original Parliament recordCannabis: Medical TreatmentsDepartment of Health and Social CareTabled 18 May 2026AnsweredUIN 1991More
Question: To ask the Secretary of State for Health and Social Care, how many investigations the Medicines and Healthcare products Regulatory Agency has opened into the (a) advertising and (b) promotion of unlicensed cannabis-based products for medicinal use by priv
Answer: The Department of Health and Social Care has worked closely with the Home Office and healthcare regulators in the development and implementation of the law change in 2018 to permit the prescribing of unlicensed cannabis-based products for medicinal use an...
Answered 1 Jun 2026
Original Parliament recordCannabis: Medical TreatmentsDepartment of Health and Social CareTabled 18 May 2026AnsweredUIN 1990More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the effectiveness of the application of Regulation 167 of the Human Medicines Regulations 2012 to the supply of unlicensed cannabis-based products f
Answer: The Department of Health and Social Care has worked closely with the Home Office and healthcare regulators in the development and implementation of the law change in 2018 to permit the prescribing of unlicensed cannabis-based products for medicinal use an...
Answered 1 Jun 2026
Original Parliament recordCannabis: Medical TreatmentsDepartment of Health and Social CareTabled 18 May 2026AnsweredUIN 1989More
Question: To ask the Secretary of State for Health and Social Care, what discussions his Department has had with the (a) Care Quality Commission, (b) General Medical Council, (c) Medicines and Healthcare products Regulatory Agency and (b) the Secretary of State for
Answer: The Department of Health and Social Care has worked closely with the Home Office and healthcare regulators in the development and implementation of the law change in 2018 to permit the prescribing of unlicensed cannabis-based products for medicinal use an...
Answered 1 Jun 2026
Original Parliament recordCannabis: Medical TreatmentsDepartment of Health and Social CareTabled 18 May 2026AnsweredUIN 1988More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure the safe prescribing of cannabis-based products for medicinal use.
Answer: The Department of Health and Social Care has worked closely with the Home Office and healthcare regulators in the development and implementation of the law change in 2018 to permit the prescribing of unlicensed cannabis-based products for medicinal use an...
Answered 1 Jun 2026
Original Parliament recordMotability: TaxationTreasuryTabled 18 May 2026AnsweredUIN 1956More
Question: To ask the Chancellor of the Exchequer, what assessment she has made of the impact of changes to tax treatment affecting the Motability Scheme from 1 July 2026 on the affordability of new leases for disabled people.
Answer: At Budget 2025 the government announced tax changes to the Motability scheme which will save over £1 billion over the next five years. The VAT relief for top-up payments made to lease more expensive vehicles will be removed for new leases from July 2026, ...
Answered 27 May 2026
Original Parliament recordMotability: SafetyDepartment for Work and PensionsTabled 18 May 2026AnsweredUIN 1955More
Question: To ask the Secretary of State for Work and Pensions, whether his Department has had discussions with Motability Operations Ltd on the potential safety implications of changes to tyre replacement limits under the Motability Scheme.
Answer: Responsibility for the terms and administration of the Scheme sits with Motability Foundation and its Board of Governors. The Department for Work and Pensions meets quarterly with Motability Foundation, to discuss the Scheme’s operation. The changes to th...
Answered 27 May 2026
Original Parliament recordHealth Services: Waiting ListsDepartment of Health and Social CareTabled 18 May 2026AnsweredUIN 1954More
Question: To ask the Secretary of State for Health and Social Care, whether (a) statutory and (b) policy rules prevent NHS funding for an elective procedure being combined with a patient contribution to meet the cost of treatment by an independent-sector provider.
Answer: Where a patient opts to pay for private care, their entitlement to services within the National Health Service remains and may not be withdrawn. However, the NHS should not subsidise private care. Therefore, it is important there is as clear a distinction...
Answered 1 Jun 2026
Original Parliament recordHealth Services: Waiting ListsDepartment of Health and Social CareTabled 18 May 2026AnsweredUIN 1953More
Question: To ask the Secretary of State for Health and Social Care, whether patients who have waited longer than 18 weeks for consultant-led elective treatment have a right to request transfer to an alternative NHS or NHS-funded independent-sector provider able to
Answer: Patients in England have a right to request their local integrated care board (ICB) find an alternative provider when they have been waiting, or expect to wait, over 18 weeks to begin treatment for consultant-led care.When notified, ICBs are required to t...
Answered 1 Jun 2026
Original Parliament record
Published records only — not a full account of an MP’s work. How we work →